Home Contact Us 中文 English
Yourlocation:Home >News> To observe the clinical therapeutic effect of trimebutine maleate in patients with irritable bowel syndrome

To observe the clinical therapeutic effect of trimebutine maleate in patients with irritable bowel syndrome

Time:2017/8/3 17:11:21

To observe the clinical therapeutic effect of trimebutine maleate in patients with irritable bowel syndrome.

96 patients with irritable bowel syndrome admitted in our hospital from January 2015 to December 2015 were selected as the subjects. The difference between the two groups was observed in the observation group and the control group, 48 patients in the control group and oral control group were observed. The patients in the observation group were treated with trimebutine maleate.

The total effective rate of the observation group was 91.7 (P <0.05) .

The results showed that the number of abdominal pain, the degree of diarrhea and the number of bowel movements per day were lower than those in the control group, and the difference was statistically significant (P <0.05). To the treatment of irritable bowel syndrome, the clinical efficacy is more reliable, and can significantly improve the patient's diarrhea, abdominal pain symptoms, defecation significantly reduced the number of worthy of promotion and application.